Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 1/2 1

Status

Terminated 1Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 56INDUSTRY 50NIH 9NETWORK 4OTHER_GOV 2

Study Type

Interventional 4

Sponsor

Cancer Type

Dermatologic 3CNS 1Breast 1

Conditions

Melanoma 3Triple Negative Breast Neoplasms 1Lymphatic Metastasis 1Brain Neoplasms 1

Interventions

Radiotherapy 302Cisplatin 266Cyclophosphamide 230Doxorubicin 177Paclitaxel 170Vincristine 162Carboplatin 152Filgrastim 140Etoposide 139Gemcitabine 118Docetaxel 114Fluorouracil 113Methotrexate 106Dexamethasone 106Cytarabine 106Prednisone 92Leucovorin 90Gene Expression Profiling 82Granulocyte Colony-Stimulating Factor 75Specimen Handling 70Magnetic Resonance Spectroscopy 63Irinotecan 59Capecitabine 59Radiation 54Polymerase Chain Reaction 51Ifosfamide 51Rituximab 49Immunohistochemistry 49Daunorubicin 49Oxaliplatin 48

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
NETWORK × binimetinib × Clear all
NCT04221438 2026-05-12

Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement

Eastern Cooperative Oncology Group

Phase 2 Terminated
3 enrolled 11 charts
Dermatologic

Lymphatic Metastasis, Melanoma

NCT04511013 2025-09-11

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

SWOG Cancer Research Network

Phase 2 Recruiting
112 enrolled
CNSDermatologic

Brain Neoplasms, Melanoma

NCT03235245 2025-08-01

EBIN

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Active not recruiting
271 enrolled
Dermatologic

Melanoma

NCT04494958 2025-03-24

PALBOBIN

Fundacion Oncosur

Phase 1/2 Completed
24 enrolled 10 charts
Breast

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡